MedTrace Logo

Investigating the Efficacy of Hair Sparing Radiotherapy Treatment to the Whole Brain.

NCT02213536 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2019-02-22

No results posted yet for this study

Summary

To investigate the use of a scalp sparing technique of radiotherapy treatment designed to treat the whole brain. Current treatment methods to treat the whole brain with radiotherapy result in complete alopecia as a side effect. Hair loss is usually patchy and uneven and re-growth similar and slow.

It is hoped that reducing the radiation dose to the hair bearing follicle on the scalp will reduce hair loss and increase the speed and evenness of re-growth.

Conditions

  • Metastatic Brain Cancer

Interventions

RADIATION

VMAT (Volumetric Modulated Arc Therapy)

Delivering a prescribed radiation dose to the whole brain using VMAT to reduce dose to hair follicles on scalp.

Sponsors & Collaborators

  • HCA International Limited

    lead OTHER

Principal Investigators

  • David Landau, DR · Clinical Oncologist with practising privilages at The Harley Street Clinic, HCA International Limited hospitals.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-02-20
Completion
2019-02-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02213536 on ClinicalTrials.gov